OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on developing and partnering therapies to control the immune system for immuno-oncology and immuno-inflammation. The company was founded by Dominique Constantini on November 17, 2004 and is headquartered in Nantes, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
64
Frequently Asked Questions
What is Market Cap of OSE Immunotherapeutics?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. OSE Immunotherapeutics market cap is $147.25M.
How many employess does OSE Immunotherapeutics has?